Notice Information
Notice Title
Continuous Positive Airway Pressure (CPAP) Service
Notice Description
Obstructive Sleep Apnoea (OSA) is a prevalent sleep-related respiratory disorder characterised by recurrent upper airway obstruction during sleep, resulting in intermittent pauses in breathing. This leads to fragmented sleep, excessive daytime sleepiness, and significantly increases the risk of developing serious comorbidities such as hypertension, diabetes, cardiovascular disease, and stroke. OSA affects approximately 5% of the population, with a substantial proportion remaining undiagnosed. The condition is particularly burdensome in individuals with coexisting chronic obstructive pulmonary disease (COPD) or obesity hypoventilation syndrome (OSAHS), where symptoms and health risks are further exacerbated. Continuous Positive Airway Pressure (CPAP) therapy is the first-line treatment for OSA, delivering a constant flow of air via a mask to maintain airway patency during sleep. Effective management requires consistent nightly use. CPAP devices typically have a lifespan of 7 years, while masks are single-patient use items requiring replacement every 6 to 12 months and regular patient cleaning to ensure optimal function and hygiene. At Gloucestershire Hospitals NHS Foundation Trust (GHNHSFT), there are currently around 5,500 patients utilising CPAP therapy and a further 300 patients using other forms of non-invasive ventilation. This generates an annual requirement for approximately 6,000 masks and tubes, and 1,200 filters. The service manages roughly 950 patient contacts per month, with half pertaining to the resupply of consumables. Diagnostic capacity was increased by 25% in 2024, resulting in a rise in therapy initiations and overall service demand. The objective of this procurement is to enhance patient access to CPAP consumables and support services, reduce administrative and storage burdens, and achieve cost efficiencies. Streamlining the supply chain and support processes will release clinical resources, improve patient experience, and reduce unplanned hospital or primary care attendances. Proactive follow-up and device recovery initiatives will support therapy adherence and ensure optimal use of resources, thereby facilitating high-quality, efficient, and patient-centred care. The core components of the required service include: - Procurement of CPAP devices and consumables - Mask management and replacement - Provision of a patient support line - Access to a patient and clinician portal - Consignment stock supply for timely distribution
Planning Information
<< PRE-MARKET ENGAGEMENT >> The Prior Information Notice serves to inform suppliers of this forthcoming procurement and to invite expressions of interest from potential suppliers wishing to participate in pre-market engagement activities. These activities will include responding to a questionnaire and attending a virtual meeting to provide feedback on the questionnaire. Gloucestershire Hospitals NHS Foundation Trust (“the Authority”) intends to hold virtual meetings during the week commencing 16 June 2025, during which suppliers will have the opportunity to discuss and elaborate on their feedback to the questionnaire. To express your interest and obtain further information regarding the questionnaire, please refer to the documentation available on Atamis, project reference ' C343012 Continuous Positive Airway Pressure (CPAP) Service’. Suppliers are encouraged to confirm their participation in the pre-market engagement activities by 26 May 2025. << COMMUNICATIONS>> All communications and enquiries regarding this procurement must be submitted via Atamis. Direct contact with Authority staff is not permitted. <<PROCUREMENT PROCESS & TIMESCALES>> The procurement route for a managed service, or a standard contract for the provision of services, may be subject to the Procurement Act 2023 Regulations. The formal procurement is expected to be published in August 2025, with the intention to complete contract award by December 2025. The Authority reserves the right to amend its approach, the scope of the procurement, the procurement procedure, and the timelines as a result of pre-market engagement or other considerations. For clarity, participation in pre-market engagement is not a prerequisite for submitting a formal bid once the procurement process commences. <<FINANCIALS>> The estimated total contract value is predicated on an anticipated annual expenditure of £625,000 (excluding VAT) in the first year. This figure is projected to increase by 25% annually to accommodate rising demand and to account for other risk related costs. The proposed contract will have an initial term of four (4) years, with the option to extend for up to an additional three (3) years. NOTE: The contract duration will be subject to review and confirmation following preliminary market engagement.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-0513c0
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/021506-2025
- Current Stage
- Planning
- All Stages
- Planning
Procurement Classification
- Notice Type
- UK2 - Preliminary Market Engagement Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Not Specified
- Procurement Method Details
- Not specified
- Tender Suitability
- SME, VCSE
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
85 - Health and social work services
-
- CPV Codes
33157000 - Gas-therapy and respiratory devices
33157400 - Medical breathing devices
33673000 - Medicinal products for obstructive airway diseases
85111700 - Oxygen-therapy services
Notice Value(s)
- Tender Value
- £9,421,000 £1M-£10M
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 14 May 20259 months ago
- Submission Deadline
- Not specified
- Future Notice Date
- 1 Aug 2025Expired
- Award Date
- Not specified
- Contract Period
- 12 Jan 2026 - 11 Jan 2030 4-5 years
- Recurrence
- Not specified
Notice Status
- Tender Status
- Planning
- Lots Status
- Planning
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- GLOUCESTERSHIRE HOSPITALS NHS FOUNDATION TRUST
- Contact Name
- Dan Kirkbride
- Contact Email
- dan.kirkbride@nhs.net
- Contact Phone
- 07766457290
Buyer Location
- Locality
- GLOUCESTER
- Postcode
- GL53 7AN
- Post Town
- Gloucester
- Country
- England
-
- Major Region (ITL 1)
- TLK South West (England)
- Basic Region (ITL 2)
- TLK7 Gloucestershire and Wiltshire
- Small Region (ITL 3)
- TLK73 Gloucestershire CC
- Delivery Location
- TLK13 Gloucestershire CC
-
- Local Authority
- Cheltenham
- Electoral Ward
- College
- Westminster Constituency
- Cheltenham
Further Information
Notice Documents
-
https://www.find-tender.service.gov.uk/Notice/021506-2025
14th May 2025 - Preliminary market engagement notice on Find a Tender
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-0513c0-2025-05-14T23:48:45+01:00",
"date": "2025-05-14T23:48:45+01:00",
"ocid": "ocds-h6vhtk-0513c0",
"initiationType": "tender",
"parties": [
{
"id": "GB-PPON-PYHT-5943-VXGV",
"name": "Gloucestershire Hospitals NHS Foundation Trust",
"identifier": {
"scheme": "GB-PPON",
"id": "PYHT-5943-VXGV"
},
"address": {
"streetAddress": "Alexandra House, Cheltenham General Hospital, Sandford Road",
"locality": "Gloucester",
"postalCode": "GL53 7AN",
"country": "GB",
"countryName": "United Kingdom",
"region": "UKK13"
},
"contactPoint": {
"name": "Dan Kirkbride",
"email": "dan.kirkbride@nhs.net",
"telephone": "07766457290"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.gloshospitals.nhs.uk/",
"classifications": [
{
"scheme": "UK_CA_TYPE",
"id": "publicAuthorityCentralGovernment",
"description": "Public authority - central government"
}
]
}
}
],
"buyer": {
"id": "GB-PPON-PYHT-5943-VXGV",
"name": "Gloucestershire Hospitals NHS Foundation Trust"
},
"planning": {
"milestones": [
{
"id": "engagement",
"type": "engagement",
"description": "<< PRE-MARKET ENGAGEMENT >> The Prior Information Notice serves to inform suppliers of this forthcoming procurement and to invite expressions of interest from potential suppliers wishing to participate in pre-market engagement activities. These activities will include responding to a questionnaire and attending a virtual meeting to provide feedback on the questionnaire. Gloucestershire Hospitals NHS Foundation Trust (\"the Authority\") intends to hold virtual meetings during the week commencing 16 June 2025, during which suppliers will have the opportunity to discuss and elaborate on their feedback to the questionnaire. To express your interest and obtain further information regarding the questionnaire, please refer to the documentation available on Atamis, project reference ' C343012 Continuous Positive Airway Pressure (CPAP) Service'. Suppliers are encouraged to confirm their participation in the pre-market engagement activities by 26 May 2025. << COMMUNICATIONS>> All communications and enquiries regarding this procurement must be submitted via Atamis. Direct contact with Authority staff is not permitted. <<PROCUREMENT PROCESS & TIMESCALES>> The procurement route for a managed service, or a standard contract for the provision of services, may be subject to the Procurement Act 2023 Regulations. The formal procurement is expected to be published in August 2025, with the intention to complete contract award by December 2025. The Authority reserves the right to amend its approach, the scope of the procurement, the procurement procedure, and the timelines as a result of pre-market engagement or other considerations. For clarity, participation in pre-market engagement is not a prerequisite for submitting a formal bid once the procurement process commences. <<FINANCIALS>> The estimated total contract value is predicated on an anticipated annual expenditure of PS625,000 (excluding VAT) in the first year. This figure is projected to increase by 25% annually to accommodate rising demand and to account for other risk related costs. The proposed contract will have an initial term of four (4) years, with the option to extend for up to an additional three (3) years. NOTE: The contract duration will be subject to review and confirmation following preliminary market engagement.",
"dueDate": "2025-06-13T23:59:59+01:00",
"status": "scheduled"
}
],
"documents": [
{
"id": "021506-2025",
"documentType": "marketEngagementNotice",
"noticeType": "UK2",
"description": "Preliminary market engagement notice on Find a Tender",
"url": "https://www.find-tender.service.gov.uk/Notice/021506-2025",
"datePublished": "2025-05-14T23:48:45+01:00",
"format": "text/html"
}
]
},
"tender": {
"id": "C343012",
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"title": "Continuous Positive Airway Pressure (CPAP) Service",
"description": "Obstructive Sleep Apnoea (OSA) is a prevalent sleep-related respiratory disorder characterised by recurrent upper airway obstruction during sleep, resulting in intermittent pauses in breathing. This leads to fragmented sleep, excessive daytime sleepiness, and significantly increases the risk of developing serious comorbidities such as hypertension, diabetes, cardiovascular disease, and stroke. OSA affects approximately 5% of the population, with a substantial proportion remaining undiagnosed. The condition is particularly burdensome in individuals with coexisting chronic obstructive pulmonary disease (COPD) or obesity hypoventilation syndrome (OSAHS), where symptoms and health risks are further exacerbated. Continuous Positive Airway Pressure (CPAP) therapy is the first-line treatment for OSA, delivering a constant flow of air via a mask to maintain airway patency during sleep. Effective management requires consistent nightly use. CPAP devices typically have a lifespan of 7 years, while masks are single-patient use items requiring replacement every 6 to 12 months and regular patient cleaning to ensure optimal function and hygiene. At Gloucestershire Hospitals NHS Foundation Trust (GHNHSFT), there are currently around 5,500 patients utilising CPAP therapy and a further 300 patients using other forms of non-invasive ventilation. This generates an annual requirement for approximately 6,000 masks and tubes, and 1,200 filters. The service manages roughly 950 patient contacts per month, with half pertaining to the resupply of consumables. Diagnostic capacity was increased by 25% in 2024, resulting in a rise in therapy initiations and overall service demand. The objective of this procurement is to enhance patient access to CPAP consumables and support services, reduce administrative and storage burdens, and achieve cost efficiencies. Streamlining the supply chain and support processes will release clinical resources, improve patient experience, and reduce unplanned hospital or primary care attendances. Proactive follow-up and device recovery initiatives will support therapy adherence and ensure optimal use of resources, thereby facilitating high-quality, efficient, and patient-centred care. The core components of the required service include: - Procurement of CPAP devices and consumables - Mask management and replacement - Provision of a patient support line - Access to a patient and clinician portal - Consignment stock supply for timely distribution",
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85111700",
"description": "Oxygen-therapy services"
},
{
"scheme": "CPV",
"id": "33157000",
"description": "Gas-therapy and respiratory devices"
},
{
"scheme": "CPV",
"id": "33157400",
"description": "Medical breathing devices"
},
{
"scheme": "CPV",
"id": "33673000",
"description": "Medicinal products for obstructive airway diseases"
}
],
"deliveryAddresses": [
{
"region": "UKK13",
"country": "GB",
"countryName": "United Kingdom"
}
],
"relatedLot": "1"
}
],
"value": {
"amountGross": 11306000,
"amount": 9421000,
"currency": "GBP"
},
"mainProcurementCategory": "services",
"additionalProcurementCategories": [
"goods"
],
"aboveThreshold": true,
"lots": [
{
"id": "1",
"suitability": {
"sme": true,
"vcse": true
},
"contractPeriod": {
"startDate": "2026-01-12T00:00:00Z",
"endDate": "2030-01-11T23:59:59Z",
"maxExtentDate": "2033-01-11T23:59:59Z"
},
"hasRenewal": true,
"status": "planning"
}
],
"communication": {
"futureNoticeDate": "2025-08-01T23:59:59+01:00"
},
"status": "planning"
},
"language": "en"
}